probenecid has been researched along with Alloxan Diabetes in 4 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Trulson, ME | 2 |
Himmel, CD | 1 |
Ennis, SR | 1 |
Jacoby, JH | 1 |
MacKenzie, RG | 1 |
Sandström, PE | 1 |
4 other studies available for probenecid and Alloxan Diabetes
Article | Year |
---|---|
Decreased brain dopamine synthesis rate and increased [3H]spiroperidol binding in streptozotocin-diabetic rats.
Topics: Animals; Brain; Butyrophenones; Diabetes Mellitus, Experimental; Dihydroxyphenylalanine; Dopamine; F | 1983 |
Permeability of the blood-ocular barrier to mannitol and PAH during experimental diabetes.
Topics: Analysis of Variance; Animals; Biological Transport, Active; Blood Volume; Blood-Retinal Barrier; Ca | 1990 |
Streptozotocin-induced diabetes reduces brain serotonin synthesis in rats.
Topics: 5-Hydroxytryptophan; Animals; Benserazide; Brain; Carboxy-Lyases; Diabetes Mellitus, Experimental; H | 1986 |
Evidence for diabetogenic action of bumetanide in mice.
Topics: Animals; Blood Glucose; Body Weight; Bumetanide; Diabetes Mellitus, Experimental; Diuresis; Diuretic | 1988 |